Certified by Founder
Lodge
Electra Therapeutics
start up

- 22/10/2025
- Series C
- $183,000,000
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
- Industry Biotechnology Research
- Website https://electra-therapeutics.com/
- LinkedIn https://www.linkedin.com/company/electra-tx/